nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2C9—brain cancer	0.696	1	CbGaD
Fosphenytoin—CYP3A4—Temozolomide—brain cancer	0.0472	0.39	CbGbCtD
Fosphenytoin—CYP3A4—Lomustine—brain cancer	0.0402	0.332	CbGbCtD
Fosphenytoin—CYP2C8—Etoposide—brain cancer	0.0239	0.198	CbGbCtD
Fosphenytoin—CYP3A4—Etoposide—brain cancer	0.0097	0.0802	CbGbCtD
Fosphenytoin—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00155	0.065	CbGpPWpGaD
Fosphenytoin—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00139	0.0585	CbGpPWpGaD
Fosphenytoin—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00128	0.0535	CbGpPWpGaD
Fosphenytoin—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00127	0.0532	CbGpPWpGaD
Fosphenytoin—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00124	0.0522	CbGpPWpGaD
Fosphenytoin—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00113	0.0475	CbGpPWpGaD
Fosphenytoin—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00108	0.0453	CbGpPWpGaD
Fosphenytoin—Phenylbutazone—CYP2C9—brain cancer	0.00102	0.404	CrCbGaD
Fosphenytoin—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000964	0.0404	CbGpPWpGaD
Fosphenytoin—Modafinil—CYP2C9—brain cancer	0.000799	0.316	CrCbGaD
Fosphenytoin—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000791	0.0332	CbGpPWpGaD
Fosphenytoin—Phenytoin—CYP2C9—brain cancer	0.000709	0.28	CrCbGaD
Fosphenytoin—Depressed level of consciousness—Temozolomide—brain cancer	0.000685	0.00437	CcSEcCtD
Fosphenytoin—Urinary incontinence—Temozolomide—brain cancer	0.000685	0.00437	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Procarbazine—brain cancer	0.000672	0.00428	CcSEcCtD
Fosphenytoin—Coma—Carmustine—brain cancer	0.00067	0.00428	CcSEcCtD
Fosphenytoin—Vaginal infection—Temozolomide—brain cancer	0.000669	0.00427	CcSEcCtD
Fosphenytoin—Apnoea—Etoposide—brain cancer	0.000669	0.00427	CcSEcCtD
Fosphenytoin—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000669	0.0281	CbGpPWpGaD
Fosphenytoin—Pneumonia—Procarbazine—brain cancer	0.00066	0.00421	CcSEcCtD
Fosphenytoin—Infection—Lomustine—brain cancer	0.000655	0.00418	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Lomustine—brain cancer	0.000645	0.00412	CcSEcCtD
Fosphenytoin—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000644	0.027	CbGpPWpGaD
Fosphenytoin—Mental disability—Carmustine—brain cancer	0.000637	0.00406	CcSEcCtD
Fosphenytoin—Sepsis—Carmustine—brain cancer	0.000637	0.00406	CcSEcCtD
Fosphenytoin—Face oedema—Hydroxyurea—brain cancer	0.000636	0.00406	CcSEcCtD
Fosphenytoin—Sweating—Procarbazine—brain cancer	0.000629	0.00401	CcSEcCtD
Fosphenytoin—Anorexia—Lomustine—brain cancer	0.000628	0.00401	CcSEcCtD
Fosphenytoin—Skin discolouration—Etoposide—brain cancer	0.000628	0.00401	CcSEcCtD
Fosphenytoin—Epistaxis—Procarbazine—brain cancer	0.000619	0.00395	CcSEcCtD
Fosphenytoin—Mental disability—Temozolomide—brain cancer	0.000615	0.00392	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Carmustine—brain cancer	0.000615	0.00392	CcSEcCtD
Fosphenytoin—Ear pain—Temozolomide—brain cancer	0.000603	0.00385	CcSEcCtD
Fosphenytoin—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000597	0.0251	CbGpPWpGaD
Fosphenytoin—Body temperature increased—Carboplatin—brain cancer	0.000596	0.0038	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Temozolomide—brain cancer	0.000595	0.00379	CcSEcCtD
Fosphenytoin—Eye pain—Carmustine—brain cancer	0.00059	0.00376	CcSEcCtD
Fosphenytoin—Injury—Carmustine—brain cancer	0.000579	0.0037	CcSEcCtD
Fosphenytoin—Deafness—Temozolomide—brain cancer	0.000575	0.00367	CcSEcCtD
Fosphenytoin—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000575	0.0241	CbGpPWpGaD
Fosphenytoin—Decreased appetite—Lomustine—brain cancer	0.000573	0.00365	CcSEcCtD
Fosphenytoin—Eye pain—Temozolomide—brain cancer	0.00057	0.00364	CcSEcCtD
Fosphenytoin—Amnesia—Carmustine—brain cancer	0.000567	0.00362	CcSEcCtD
Fosphenytoin—Amnesia—Temozolomide—brain cancer	0.000548	0.00349	CcSEcCtD
Fosphenytoin—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000543	0.0228	CbGpPWpGaD
Fosphenytoin—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000533	0.0034	CcSEcCtD
Fosphenytoin—Diplopia—Carmustine—brain cancer	0.000533	0.0034	CcSEcCtD
Fosphenytoin—Dysuria—Hydroxyurea—brain cancer	0.000533	0.0034	CcSEcCtD
Fosphenytoin—Chills—Procarbazine—brain cancer	0.000528	0.00337	CcSEcCtD
Fosphenytoin—Body temperature increased—Lomustine—brain cancer	0.000521	0.00332	CcSEcCtD
Fosphenytoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000517	0.0217	CbGpPWpGaD
Fosphenytoin—Rash maculo-papular—Etoposide—brain cancer	0.000516	0.00329	CcSEcCtD
Fosphenytoin—Diplopia—Temozolomide—brain cancer	0.000515	0.00328	CcSEcCtD
Fosphenytoin—Face oedema—Carmustine—brain cancer	0.000514	0.00328	CcSEcCtD
Fosphenytoin—Affect lability—Temozolomide—brain cancer	0.000507	0.00323	CcSEcCtD
Fosphenytoin—Tension—Procarbazine—brain cancer	0.000503	0.00321	CcSEcCtD
Fosphenytoin—Ataxia—Carmustine—brain cancer	0.000501	0.00319	CcSEcCtD
Fosphenytoin—Nervousness—Procarbazine—brain cancer	0.000498	0.00318	CcSEcCtD
Fosphenytoin—Face oedema—Temozolomide—brain cancer	0.000497	0.00317	CcSEcCtD
Fosphenytoin—Sepsis—Etoposide—brain cancer	0.000492	0.00314	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Carmustine—brain cancer	0.000492	0.00314	CcSEcCtD
Fosphenytoin—Mood swings—Temozolomide—brain cancer	0.000488	0.00311	CcSEcCtD
Fosphenytoin—Hypokalaemia—Carmustine—brain cancer	0.000485	0.00309	CcSEcCtD
Fosphenytoin—Ataxia—Temozolomide—brain cancer	0.000484	0.00309	CcSEcCtD
Fosphenytoin—Tremor—Procarbazine—brain cancer	0.00048	0.00306	CcSEcCtD
Fosphenytoin—Dehydration—Temozolomide—brain cancer	0.000479	0.00305	CcSEcCtD
Fosphenytoin—Anaemia—Procarbazine—brain cancer	0.000474	0.00302	CcSEcCtD
Fosphenytoin—Muscular weakness—Carmustine—brain cancer	0.00047	0.003	CcSEcCtD
Fosphenytoin—Hypokalaemia—Temozolomide—brain cancer	0.000468	0.00299	CcSEcCtD
Fosphenytoin—Dysphagia—Carmustine—brain cancer	0.00046	0.00294	CcSEcCtD
Fosphenytoin—Syncope—Procarbazine—brain cancer	0.00046	0.00293	CcSEcCtD
Fosphenytoin—Leukopenia—Procarbazine—brain cancer	0.000459	0.00293	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Etoposide—brain cancer	0.000454	0.0029	CcSEcCtD
Fosphenytoin—Muscular weakness—Temozolomide—brain cancer	0.000454	0.0029	CcSEcCtD
Fosphenytoin—Loss of consciousness—Procarbazine—brain cancer	0.000451	0.00287	CcSEcCtD
Fosphenytoin—Cough—Procarbazine—brain cancer	0.000447	0.00285	CcSEcCtD
Fosphenytoin—Dysphagia—Temozolomide—brain cancer	0.000445	0.00284	CcSEcCtD
Fosphenytoin—Convulsion—Procarbazine—brain cancer	0.000444	0.00283	CcSEcCtD
Fosphenytoin—Hypertension—Procarbazine—brain cancer	0.000443	0.00282	CcSEcCtD
Fosphenytoin—Arthralgia—Procarbazine—brain cancer	0.000436	0.00278	CcSEcCtD
Fosphenytoin—Myalgia—Procarbazine—brain cancer	0.000436	0.00278	CcSEcCtD
Fosphenytoin—Bronchitis—Temozolomide—brain cancer	0.000428	0.00273	CcSEcCtD
Fosphenytoin—Dry mouth—Procarbazine—brain cancer	0.000427	0.00272	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Etoposide—brain cancer	0.000426	0.00271	CcSEcCtD
Fosphenytoin—Confusional state—Procarbazine—brain cancer	0.000422	0.00269	CcSEcCtD
Fosphenytoin—Vomiting—Lomustine—brain cancer	0.000419	0.00267	CcSEcCtD
Fosphenytoin—Dysuria—Temozolomide—brain cancer	0.000416	0.00265	CcSEcCtD
Fosphenytoin—Infection—Procarbazine—brain cancer	0.000416	0.00265	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Carmustine—brain cancer	0.000415	0.00265	CcSEcCtD
Fosphenytoin—Pneumonia—Carmustine—brain cancer	0.000413	0.00263	CcSEcCtD
Fosphenytoin—Shock—Procarbazine—brain cancer	0.000412	0.00263	CcSEcCtD
Fosphenytoin—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00041	0.0172	CbGpPWpGaD
Fosphenytoin—Thrombocytopenia—Procarbazine—brain cancer	0.00041	0.00261	CcSEcCtD
Fosphenytoin—Chills—Hydroxyurea—brain cancer	0.000409	0.00261	CcSEcCtD
Fosphenytoin—Tachycardia—Procarbazine—brain cancer	0.000408	0.0026	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Temozolomide—brain cancer	0.000406	0.00259	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Procarbazine—brain cancer	0.000405	0.00258	CcSEcCtD
Fosphenytoin—Renal failure—Carmustine—brain cancer	0.000403	0.00257	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Temozolomide—brain cancer	0.000401	0.00256	CcSEcCtD
Fosphenytoin—Pneumonia—Temozolomide—brain cancer	0.000399	0.00254	CcSEcCtD
Fosphenytoin—Anorexia—Procarbazine—brain cancer	0.000399	0.00254	CcSEcCtD
Fosphenytoin—Cardiac arrest—Etoposide—brain cancer	0.000392	0.0025	CcSEcCtD
Fosphenytoin—Nausea—Lomustine—brain cancer	0.000391	0.0025	CcSEcCtD
Fosphenytoin—Hypotension—Procarbazine—brain cancer	0.000391	0.00249	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000381	0.00243	CcSEcCtD
Fosphenytoin—Insomnia—Procarbazine—brain cancer	0.000378	0.00241	CcSEcCtD
Fosphenytoin—Paraesthesia—Procarbazine—brain cancer	0.000376	0.0024	CcSEcCtD
Fosphenytoin—Sinusitis—Temozolomide—brain cancer	0.000372	0.00237	CcSEcCtD
Fosphenytoin—Somnolence—Procarbazine—brain cancer	0.000372	0.00237	CcSEcCtD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—HES5—brain cancer	0.000371	0.0156	CbGpPWpGaD
Fosphenytoin—Ill-defined disorder—Hydroxyurea—brain cancer	0.000368	0.00235	CcSEcCtD
Fosphenytoin—Anaemia—Hydroxyurea—brain cancer	0.000367	0.00234	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Carmustine—brain cancer	0.000367	0.00234	CcSEcCtD
Fosphenytoin—Decreased appetite—Procarbazine—brain cancer	0.000364	0.00232	CcSEcCtD
Fosphenytoin—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000359	0.0151	CbGpPWpGaD
Fosphenytoin—Malaise—Hydroxyurea—brain cancer	0.000358	0.00228	CcSEcCtD
Fosphenytoin—Constipation—Procarbazine—brain cancer	0.000358	0.00228	CcSEcCtD
Fosphenytoin—Dysphagia—Etoposide—brain cancer	0.000356	0.00227	CcSEcCtD
Fosphenytoin—Leukopenia—Hydroxyurea—brain cancer	0.000355	0.00227	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Temozolomide—brain cancer	0.000354	0.00226	CcSEcCtD
Fosphenytoin—Pharyngitis—Temozolomide—brain cancer	0.000353	0.00225	CcSEcCtD
Fosphenytoin—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000345	0.0145	CbGpPWpGaD
Fosphenytoin—Feeling abnormal—Procarbazine—brain cancer	0.000345	0.0022	CcSEcCtD
Fosphenytoin—Convulsion—Hydroxyurea—brain cancer	0.000344	0.00219	CcSEcCtD
Fosphenytoin—Discomfort—Hydroxyurea—brain cancer	0.000334	0.00213	CcSEcCtD
Fosphenytoin—Urticaria—Procarbazine—brain cancer	0.000332	0.00212	CcSEcCtD
Fosphenytoin—Tinnitus—Temozolomide—brain cancer	0.000332	0.00212	CcSEcCtD
Fosphenytoin—Body temperature increased—Procarbazine—brain cancer	0.000331	0.00211	CcSEcCtD
Fosphenytoin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000328	0.0138	CbGpPWpGaD
Fosphenytoin—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000324	0.0136	CbGpPWpGaD
Fosphenytoin—Infection—Hydroxyurea—brain cancer	0.000322	0.00205	CcSEcCtD
Fosphenytoin—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000322	0.0135	CbGpPWpGaD
Fosphenytoin—Chills—Temozolomide—brain cancer	0.00032	0.00204	CcSEcCtD
Fosphenytoin—Pneumonia—Etoposide—brain cancer	0.000319	0.00204	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000317	0.00202	CcSEcCtD
Fosphenytoin—Renal failure—Etoposide—brain cancer	0.000312	0.00199	CcSEcCtD
Fosphenytoin—Back pain—Carmustine—brain cancer	0.00031	0.00198	CcSEcCtD
Fosphenytoin—Anorexia—Hydroxyurea—brain cancer	0.000309	0.00197	CcSEcCtD
Fosphenytoin—Dysgeusia—Temozolomide—brain cancer	0.000304	0.00194	CcSEcCtD
Fosphenytoin—Tremor—Carmustine—brain cancer	0.000301	0.00192	CcSEcCtD
Fosphenytoin—Asthenia—Procarbazine—brain cancer	0.0003	0.00191	CcSEcCtD
Fosphenytoin—Back pain—Temozolomide—brain cancer	0.0003	0.00191	CcSEcCtD
Fosphenytoin—Anaemia—Carmustine—brain cancer	0.000296	0.00189	CcSEcCtD
Fosphenytoin—Pruritus—Procarbazine—brain cancer	0.000296	0.00189	CcSEcCtD
Fosphenytoin—Agitation—Carmustine—brain cancer	0.000295	0.00188	CcSEcCtD
Fosphenytoin—Tremor—Temozolomide—brain cancer	0.00029	0.00185	CcSEcCtD
Fosphenytoin—Dyspnoea—Hydroxyurea—brain cancer	0.000289	0.00184	CcSEcCtD
Fosphenytoin—Somnolence—Hydroxyurea—brain cancer	0.000288	0.00184	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Temozolomide—brain cancer	0.000288	0.00183	CcSEcCtD
Fosphenytoin—Leukopenia—Carmustine—brain cancer	0.000287	0.00183	CcSEcCtD
Fosphenytoin—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000287	0.012	CbGpPWpGaD
Fosphenytoin—Anaemia—Temozolomide—brain cancer	0.000287	0.00183	CcSEcCtD
Fosphenytoin—Diarrhoea—Procarbazine—brain cancer	0.000286	0.00183	CcSEcCtD
Fosphenytoin—Dyspepsia—Hydroxyurea—brain cancer	0.000285	0.00182	CcSEcCtD
Fosphenytoin—Agitation—Temozolomide—brain cancer	0.000285	0.00182	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Etoposide—brain cancer	0.000284	0.00181	CcSEcCtD
Fosphenytoin—Decreased appetite—Hydroxyurea—brain cancer	0.000282	0.0018	CcSEcCtD
Fosphenytoin—Malaise—Temozolomide—brain cancer	0.00028	0.00178	CcSEcCtD
Fosphenytoin—Vertigo—Temozolomide—brain cancer	0.000279	0.00178	CcSEcCtD
Fosphenytoin—Convulsion—Carmustine—brain cancer	0.000278	0.00177	CcSEcCtD
Fosphenytoin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000278	0.0117	CbGpPWpGaD
Fosphenytoin—Leukopenia—Temozolomide—brain cancer	0.000277	0.00177	CcSEcCtD
Fosphenytoin—Hypertension—Carmustine—brain cancer	0.000277	0.00177	CcSEcCtD
Fosphenytoin—Constipation—Hydroxyurea—brain cancer	0.000277	0.00177	CcSEcCtD
Fosphenytoin—Dizziness—Procarbazine—brain cancer	0.000277	0.00176	CcSEcCtD
Fosphenytoin—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—brain cancer	0.000277	0.0116	CbGpPWpGaD
Fosphenytoin—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000274	0.0115	CbGpPWpGaD
Fosphenytoin—Palpitations—Temozolomide—brain cancer	0.000274	0.00175	CcSEcCtD
Fosphenytoin—Myalgia—Carmustine—brain cancer	0.000273	0.00174	CcSEcCtD
Fosphenytoin—Cough—Temozolomide—brain cancer	0.00027	0.00173	CcSEcCtD
Fosphenytoin—Convulsion—Temozolomide—brain cancer	0.000269	0.00171	CcSEcCtD
Fosphenytoin—Hypertension—Temozolomide—brain cancer	0.000268	0.00171	CcSEcCtD
Fosphenytoin—Feeling abnormal—Hydroxyurea—brain cancer	0.000267	0.0017	CcSEcCtD
Fosphenytoin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000266	0.0112	CbGpPWpGaD
Fosphenytoin—Vomiting—Procarbazine—brain cancer	0.000266	0.0017	CcSEcCtD
Fosphenytoin—Confusional state—Carmustine—brain cancer	0.000264	0.00168	CcSEcCtD
Fosphenytoin—Arthralgia—Temozolomide—brain cancer	0.000264	0.00168	CcSEcCtD
Fosphenytoin—Myalgia—Temozolomide—brain cancer	0.000264	0.00168	CcSEcCtD
Fosphenytoin—Rash—Procarbazine—brain cancer	0.000264	0.00168	CcSEcCtD
Fosphenytoin—Dermatitis—Procarbazine—brain cancer	0.000264	0.00168	CcSEcCtD
Fosphenytoin—Headache—Procarbazine—brain cancer	0.000262	0.00167	CcSEcCtD
Fosphenytoin—Discomfort—Temozolomide—brain cancer	0.000261	0.00166	CcSEcCtD
Fosphenytoin—Infection—Carmustine—brain cancer	0.00026	0.00166	CcSEcCtD
Fosphenytoin—Dry mouth—Temozolomide—brain cancer	0.000258	0.00165	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Carmustine—brain cancer	0.000256	0.00163	CcSEcCtD
Fosphenytoin—Body temperature increased—Hydroxyurea—brain cancer	0.000256	0.00163	CcSEcCtD
Fosphenytoin—Chills—Etoposide—brain cancer	0.000256	0.00163	CcSEcCtD
Fosphenytoin—Tachycardia—Carmustine—brain cancer	0.000256	0.00163	CcSEcCtD
Fosphenytoin—Confusional state—Temozolomide—brain cancer	0.000255	0.00163	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Temozolomide—brain cancer	0.000253	0.00161	CcSEcCtD
Fosphenytoin—Infection—Temozolomide—brain cancer	0.000251	0.0016	CcSEcCtD
Fosphenytoin—Anorexia—Carmustine—brain cancer	0.00025	0.00159	CcSEcCtD
Fosphenytoin—Nausea—Procarbazine—brain cancer	0.000249	0.00159	CcSEcCtD
Fosphenytoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000248	0.0104	CbGpPWpGaD
Fosphenytoin—Thrombocytopenia—Temozolomide—brain cancer	0.000248	0.00158	CcSEcCtD
Fosphenytoin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000247	0.0104	CbGpPWpGaD
Fosphenytoin—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000245	0.0103	CbGpPWpGaD
Fosphenytoin—Hypotension—Carmustine—brain cancer	0.000245	0.00156	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Temozolomide—brain cancer	0.000245	0.00156	CcSEcCtD
Fosphenytoin—Dysgeusia—Etoposide—brain cancer	0.000243	0.00155	CcSEcCtD
Fosphenytoin—Anorexia—Temozolomide—brain cancer	0.000241	0.00154	CcSEcCtD
Fosphenytoin—Back pain—Etoposide—brain cancer	0.00024	0.00153	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000239	0.00152	CcSEcCtD
Fosphenytoin—Muscle spasms—Etoposide—brain cancer	0.000238	0.00152	CcSEcCtD
Fosphenytoin—Insomnia—Carmustine—brain cancer	0.000237	0.00151	CcSEcCtD
Fosphenytoin—Paraesthesia—Carmustine—brain cancer	0.000235	0.0015	CcSEcCtD
Fosphenytoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000235	0.00986	CbGpPWpGaD
Fosphenytoin—Dyspnoea—Carmustine—brain cancer	0.000233	0.00149	CcSEcCtD
Fosphenytoin—Somnolence—Carmustine—brain cancer	0.000233	0.00148	CcSEcCtD
Fosphenytoin—Asthenia—Hydroxyurea—brain cancer	0.000232	0.00148	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00023	0.00147	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Etoposide—brain cancer	0.00023	0.00147	CcSEcCtD
Fosphenytoin—Anaemia—Etoposide—brain cancer	0.000229	0.00146	CcSEcCtD
Fosphenytoin—Insomnia—Temozolomide—brain cancer	0.000229	0.00146	CcSEcCtD
Fosphenytoin—Decreased appetite—Carmustine—brain cancer	0.000228	0.00145	CcSEcCtD
Fosphenytoin—Paraesthesia—Temozolomide—brain cancer	0.000227	0.00145	CcSEcCtD
Fosphenytoin—Dyspnoea—Temozolomide—brain cancer	0.000226	0.00144	CcSEcCtD
Fosphenytoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000225	0.00945	CbGpPWpGaD
Fosphenytoin—Somnolence—Temozolomide—brain cancer	0.000225	0.00143	CcSEcCtD
Fosphenytoin—Constipation—Carmustine—brain cancer	0.000224	0.00143	CcSEcCtD
Fosphenytoin—Malaise—Etoposide—brain cancer	0.000224	0.00143	CcSEcCtD
Fosphenytoin—Vertigo—Etoposide—brain cancer	0.000223	0.00142	CcSEcCtD
Fosphenytoin—Dyspepsia—Temozolomide—brain cancer	0.000223	0.00142	CcSEcCtD
Fosphenytoin—Leukopenia—Etoposide—brain cancer	0.000222	0.00142	CcSEcCtD
Fosphenytoin—Diarrhoea—Hydroxyurea—brain cancer	0.000222	0.00141	CcSEcCtD
Fosphenytoin—Decreased appetite—Temozolomide—brain cancer	0.00022	0.0014	CcSEcCtD
Fosphenytoin—Loss of consciousness—Etoposide—brain cancer	0.000218	0.00139	CcSEcCtD
Fosphenytoin—Cough—Etoposide—brain cancer	0.000216	0.00138	CcSEcCtD
Fosphenytoin—Constipation—Temozolomide—brain cancer	0.000216	0.00138	CcSEcCtD
Fosphenytoin—Feeling abnormal—Carmustine—brain cancer	0.000216	0.00138	CcSEcCtD
Fosphenytoin—Convulsion—Etoposide—brain cancer	0.000215	0.00137	CcSEcCtD
Fosphenytoin—Hypertension—Etoposide—brain cancer	0.000214	0.00137	CcSEcCtD
Fosphenytoin—Dizziness—Hydroxyurea—brain cancer	0.000214	0.00137	CcSEcCtD
Fosphenytoin—Discomfort—Etoposide—brain cancer	0.000209	0.00133	CcSEcCtD
Fosphenytoin—Feeling abnormal—Temozolomide—brain cancer	0.000208	0.00133	CcSEcCtD
Fosphenytoin—Body temperature increased—Carmustine—brain cancer	0.000207	0.00132	CcSEcCtD
Fosphenytoin—Vomiting—Hydroxyurea—brain cancer	0.000206	0.00131	CcSEcCtD
Fosphenytoin—Rash—Hydroxyurea—brain cancer	0.000204	0.0013	CcSEcCtD
Fosphenytoin—Confusional state—Etoposide—brain cancer	0.000204	0.0013	CcSEcCtD
Fosphenytoin—Dermatitis—Hydroxyurea—brain cancer	0.000204	0.0013	CcSEcCtD
Fosphenytoin—Headache—Hydroxyurea—brain cancer	0.000203	0.00129	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Etoposide—brain cancer	0.000202	0.00129	CcSEcCtD
Fosphenytoin—Infection—Etoposide—brain cancer	0.000201	0.00128	CcSEcCtD
Fosphenytoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000201	0.00844	CbGpPWpGaD
Fosphenytoin—Urticaria—Temozolomide—brain cancer	0.000201	0.00128	CcSEcCtD
Fosphenytoin—Body temperature increased—Temozolomide—brain cancer	0.0002	0.00128	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Etoposide—brain cancer	0.000198	0.00126	CcSEcCtD
Fosphenytoin—Tachycardia—Etoposide—brain cancer	0.000198	0.00126	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Etoposide—brain cancer	0.000196	0.00125	CcSEcCtD
Fosphenytoin—Anorexia—Etoposide—brain cancer	0.000193	0.00123	CcSEcCtD
Fosphenytoin—Nausea—Hydroxyurea—brain cancer	0.000192	0.00123	CcSEcCtD
Fosphenytoin—Hypotension—Etoposide—brain cancer	0.000189	0.00121	CcSEcCtD
Fosphenytoin—Asthenia—Carmustine—brain cancer	0.000188	0.0012	CcSEcCtD
Fosphenytoin—Paraesthesia—Etoposide—brain cancer	0.000182	0.00116	CcSEcCtD
Fosphenytoin—Asthenia—Temozolomide—brain cancer	0.000182	0.00116	CcSEcCtD
Fosphenytoin—Dyspnoea—Etoposide—brain cancer	0.00018	0.00115	CcSEcCtD
Fosphenytoin—Somnolence—Etoposide—brain cancer	0.00018	0.00115	CcSEcCtD
Fosphenytoin—Diarrhoea—Carmustine—brain cancer	0.000179	0.00114	CcSEcCtD
Fosphenytoin—Pruritus—Temozolomide—brain cancer	0.000179	0.00114	CcSEcCtD
Fosphenytoin—Decreased appetite—Etoposide—brain cancer	0.000176	0.00112	CcSEcCtD
Fosphenytoin—Dizziness—Carmustine—brain cancer	0.000173	0.0011	CcSEcCtD
Fosphenytoin—Constipation—Etoposide—brain cancer	0.000173	0.0011	CcSEcCtD
Fosphenytoin—Diarrhoea—Temozolomide—brain cancer	0.000173	0.0011	CcSEcCtD
Fosphenytoin—Dizziness—Temozolomide—brain cancer	0.000167	0.00107	CcSEcCtD
Fosphenytoin—Feeling abnormal—Etoposide—brain cancer	0.000167	0.00106	CcSEcCtD
Fosphenytoin—Vomiting—Carmustine—brain cancer	0.000166	0.00106	CcSEcCtD
Fosphenytoin—Rash—Carmustine—brain cancer	0.000165	0.00105	CcSEcCtD
Fosphenytoin—Dermatitis—Carmustine—brain cancer	0.000165	0.00105	CcSEcCtD
Fosphenytoin—Headache—Carmustine—brain cancer	0.000164	0.00105	CcSEcCtD
Fosphenytoin—Vomiting—Temozolomide—brain cancer	0.000161	0.00103	CcSEcCtD
Fosphenytoin—Urticaria—Etoposide—brain cancer	0.000161	0.00103	CcSEcCtD
Fosphenytoin—Body temperature increased—Etoposide—brain cancer	0.00016	0.00102	CcSEcCtD
Fosphenytoin—Rash—Temozolomide—brain cancer	0.00016	0.00102	CcSEcCtD
Fosphenytoin—Dermatitis—Temozolomide—brain cancer	0.000159	0.00102	CcSEcCtD
Fosphenytoin—Headache—Temozolomide—brain cancer	0.000158	0.00101	CcSEcCtD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000158	0.00662	CbGpPWpGaD
Fosphenytoin—Nausea—Carmustine—brain cancer	0.000156	0.000992	CcSEcCtD
Fosphenytoin—Nausea—Temozolomide—brain cancer	0.00015	0.000958	CcSEcCtD
Fosphenytoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000149	0.00626	CbGpPWpGaD
Fosphenytoin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000147	0.00618	CbGpPWpGaD
Fosphenytoin—Asthenia—Etoposide—brain cancer	0.000145	0.000926	CcSEcCtD
Fosphenytoin—Pruritus—Etoposide—brain cancer	0.000143	0.000913	CcSEcCtD
Fosphenytoin—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000141	0.00593	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000139	0.00585	CbGpPWpGaD
Fosphenytoin—Diarrhoea—Etoposide—brain cancer	0.000139	0.000883	CcSEcCtD
Fosphenytoin—Dizziness—Etoposide—brain cancer	0.000134	0.000854	CcSEcCtD
Fosphenytoin—Vomiting—Etoposide—brain cancer	0.000129	0.000821	CcSEcCtD
Fosphenytoin—Rash—Etoposide—brain cancer	0.000128	0.000814	CcSEcCtD
Fosphenytoin—Dermatitis—Etoposide—brain cancer	0.000128	0.000813	CcSEcCtD
Fosphenytoin—Headache—Etoposide—brain cancer	0.000127	0.000809	CcSEcCtD
Fosphenytoin—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000127	0.00532	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000123	0.00514	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—HES1—brain cancer	0.000123	0.00514	CbGpPWpGaD
Fosphenytoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000121	0.00507	CbGpPWpGaD
Fosphenytoin—Nausea—Etoposide—brain cancer	0.00012	0.000767	CcSEcCtD
Fosphenytoin—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.00012	0.00502	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000118	0.00495	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000113	0.00473	CbGpPWpGaD
Fosphenytoin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000112	0.00472	CbGpPWpGaD
Fosphenytoin—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000107	0.00448	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—TRPC6—brain cancer	0.000106	0.00445	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000105	0.00442	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—SOD2—brain cancer	9.18e-05	0.00385	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—TRPC6—brain cancer	7.56e-05	0.00317	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—SOD2—brain cancer	7.29e-05	0.00306	CbGpPWpGaD
Fosphenytoin—SCN5A—L1CAM interactions—EGFR—brain cancer	7.18e-05	0.00301	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—RELA—brain cancer	6.52e-05	0.00274	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.42e-05	0.0027	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.34e-05	0.00266	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—MPL—brain cancer	6.32e-05	0.00265	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	6.14e-05	0.00258	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—S100A10—brain cancer	6.06e-05	0.00254	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	5.43e-05	0.00228	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.41e-05	0.00227	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—RELA—brain cancer	5.3e-05	0.00223	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	5.24e-05	0.0022	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—HES1—brain cancer	4.87e-05	0.00204	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—IL2—brain cancer	4.78e-05	0.002	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.6e-05	0.00193	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.57e-05	0.00192	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—BSG—brain cancer	4.27e-05	0.00179	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—RELA—brain cancer	4.21e-05	0.00177	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.1e-05	0.00172	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	4.07e-05	0.00171	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—ERBB2—brain cancer	3.91e-05	0.00164	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—CDK4—brain cancer	3.82e-05	0.0016	CbGpPWpGaD
Fosphenytoin—ALB—Platelet degranulation—VEGFA—brain cancer	3.48e-05	0.00146	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.36e-05	0.00141	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.34e-05	0.0014	CbGpPWpGaD
Fosphenytoin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	3.32e-05	0.00139	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—TP53—brain cancer	3.07e-05	0.00129	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—VEGFA—brain cancer	3.01e-05	0.00126	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3e-05	0.00126	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—RELA—brain cancer	2.81e-05	0.00118	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TRPC6—brain cancer	2.8e-05	0.00117	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—ERBB2—brain cancer	2.79e-05	0.00117	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.73e-05	0.00115	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—EGFR—brain cancer	2.71e-05	0.00114	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	2.58e-05	0.00108	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—CTNNB1—brain cancer	2.44e-05	0.00103	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	2.42e-05	0.00102	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP2C9—brain cancer	2.42e-05	0.00101	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—VEGFA—brain cancer	2.15e-05	0.000903	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—STAT3—brain cancer	2.13e-05	0.000894	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VAV1—brain cancer	2.1e-05	0.00088	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—BSG—brain cancer	2.06e-05	0.000863	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP2C9—brain cancer	2.05e-05	0.000859	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP2C9—brain cancer	2.04e-05	0.000854	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—EGFR—brain cancer	1.94e-05	0.000812	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP2C9—brain cancer	1.83e-05	0.000767	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	1.82e-05	0.000762	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—IDH1—brain cancer	1.77e-05	0.000742	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—BSG—brain cancer	1.74e-05	0.00073	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—BSG—brain cancer	1.73e-05	0.000726	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—BSG—brain cancer	1.55e-05	0.000652	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.54e-05	0.000648	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—IDH1—brain cancer	1.5e-05	0.000628	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—IDH1—brain cancer	1.49e-05	0.000624	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—BSG—brain cancer	1.42e-05	0.000594	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ENO2—brain cancer	1.4e-05	0.000586	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—IDH1—brain cancer	1.34e-05	0.000561	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CG—brain cancer	1.33e-05	0.000558	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.22e-05	0.000511	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—IDH1—brain cancer	1.22e-05	0.000511	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.21e-05	0.000508	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ENO2—brain cancer	1.18e-05	0.000496	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ENO2—brain cancer	1.18e-05	0.000494	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP2C9—brain cancer	1.1e-05	0.000461	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.09e-05	0.000456	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ENO2—brain cancer	1.06e-05	0.000443	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.92e-06	0.000416	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ENO2—brain cancer	9.63e-06	0.000404	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IL2—brain cancer	9.37e-06	0.000393	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—BSG—brain cancer	9.34e-06	0.000392	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—IDH1—brain cancer	8.03e-06	0.000337	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VEGFA—brain cancer	7.96e-06	0.000334	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CG—brain cancer	6.41e-06	0.000269	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ENO2—brain cancer	6.35e-06	0.000266	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TP53—brain cancer	6.01e-06	0.000252	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CG—brain cancer	5.43e-06	0.000228	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CG—brain cancer	5.4e-06	0.000226	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CG—brain cancer	4.84e-06	0.000203	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CG—brain cancer	4.42e-06	0.000185	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CG—brain cancer	2.91e-06	0.000122	CbGpPWpGaD
